Medine.co.uk

Gaviscon Double Action Mint

Document: label-leaflet MAH BRAND_PL 00063-0525 change

Height

26mm



a

o

to

tO

LJ

PRINTING READS This Way


Aep e saiup" jnoj o) dn 'ewppeq p pue s|Eadj jaye spiqe} jnoj. oj omj a^epnaao SLUojdujAs uaq/\/\ :jbao pue sjeaA Zi uajp|ji|3 pue )|npv 'Bu|mo||3ms ' ajopq AiqBnojoqi/waqo 'uqjiejismjmpejejo Jojj^gysQQ


(sjsojodoaiso joj) sapuoqdsoqdsjq pue (eue|Biu jo^) amnbojoiqo 'emxojAqj '(ss3U||| |epaw joj.) sagdaiojnau '{suopipuas jjsaq joj) sja>joo|q-epq pue ujxoBjp '3|ozeuoaop>| se qons s| e Bu n jpu e'suopej ed a jduoj]


'(u;oexo|jjou se qons sauopumY pue sempAoejpj) sapoiqpue 'sau|iue]S|qpue Buppjaje noA |i juejjodiui Ajiejoadsa s| sjqj. ■saupipaiu jeqp aiuos p uopoe aqi qi|M ajajjaiw ueo p se qpow Apssujbjpsuj jayp Suppi psjnoq


o«u ujqijM pnpojd sjqi a>|ei )0u og suujujpui/i juqio Buji|ei

■Bmpeej jseajq jo peuBejd sje noA || pnpojd sjq; a>|eiuea noA ■suonoeaj ojBjsne asnea Abuj l|0|ljaa '(3213) a>|e| aujsjouijop uieiuob spigej asagj_


'3U|ue|e|Auaqd e pesyrpe uaaq 3Aeq noA || uinioieo    -jsaqo jnoA"u| metfBmujnq"

|o aajnos e 'aweuedse joiuiug^ pue iun|pos |oiuuiyg-6 teqi aqpos o; sjuapoo qbepojs aqi qi|M pauajaaMS s| jonpojd smepoo asop jaiqejjno| qoeg '(is|| jbao jameq aAyoajojd e Bujiujoj aqije'qiajou'e|jnuoia)||Auaqd ||n| e jo| uogewjop! jaqunj aas)    'iiojiuoosip aAa||aj 01

3Aeq noA|| ■pnpojd s|qi Bu|>|eq. s|ua|pajBu| aqi|0 Aue 01 ojBja||e ppe qoeiuojs ssaoxa Bu|S||ejjna[\| t ajojaq jopop jnoA >|se asea|d aje noA jeqi aaou>| noA || a>|ei jou oa    :sAbm o/wi m >|jom Aaq_[

asaqijoj ayjiauppap 1 jpajjajp JiaflflDHdSIH19NDIV13UQJ33__ _______ -uojjsaBipuijJue


ujnqpeaL) p po|Luoosjp pue medj aqi luoj| |3||aj Buuq spjqei asaqu apuoqjeo uinpiea apuoqjeojq uuiipos aieuiBp uimpos siaiavi 3iavAA3H3 unoAvij : JLN11AI N0llQV3iaQ0Q nqisiavjl


■Manufacturer arifl PL Holder iri"UK: Reckitt Benckiser Healthcare (UK) Ltd., Hull, HU87DS.

“i


.0000



300


>;


Children untler12 years: Should Be taken on AITERTAKINIiTHI5~PRDD0(nT

medical advice.    If symptoms persist after 7 days

If you forget a dose: Do not double the dose next consult your doctor, time, just carry on as before.    POSSIBLE SIDE EFFECTS:

If you take too much of this product: You may Very rarely (less than 1 in 10,000 (feel bloated. It is unlikely to cause you any harm, patients treated) an allergic but please consult ypur_dpctor_o_r pharmacist. _ _ reaction tojhejngredients may.


"occur. Symptoms of this may include skin rash, itching, difficulty breathing, dizziness, or swelling of the face, lips, tongue or throat. If you experience these or any other side-effects stop taking the product and_c0ns_uIt your doct_or_______


"immediately.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at


"www.mbra.gov.ulr/yellbwcard By reporting side effects you can help provide more information on the safety of this medicine. FURTHER INFORMATION: Each tablet contains 250mg sodium alginate,_106jinig so_dium_____


"bicarbonate and!87^mg calcium carmolslneTalre (ET22J7

carbonate as the active ingredients. These tablets are sugar and gluten

The tablets also contain xylitol, free.

carmellose sodium, magnesium

stearate, macrogol 20,000, mannitol

(E421), copovidone, acesulfame-K,

asj)arta_m_eJE951J,_mjntflavpur_and__________________012586.3


PATIENT INFORMATION LEAFLE1!

| Gaviscori Doable Action Mirit Flavour Chewable Tablets Sodium alginate, Sodium bicarbonate, Calcium Carbonate

[Please read this} leaflet carefully before you take this njedicine.

[If you are not sure about anything* ask your pharmacist or doctor. ^Yhat are Gaviscon Double Actioif Mint Flavour Chefvable Tablets?

[Gaviscon Doubl[e Action Mint Flavo[ur Chewable Tablet^ are a Combination of two antacids (calcium carbonate and sodium bicarbonate) and an alginate and work in two ways:    I

[l)Neutralising excess stomach acid to relieve the pain and discomfort.

£) Forming a protective barrier over [the stomach content^ to soothe the [ burning pain in your chest.    [    [

^rVhat are Gaviscon Double Action[ Mint Flavour Chefvable Tablets used for? 1    1    1

II    I    I

paviscon Double Action Mint Flavour Chewable Tablet^ are used for the treatment ofisymptoms of gastro*oesophageal reflux such as acid regurgitation, heartburn and indigestion which may occur, for example, [following meals[ or during pregnancy, and for symptoms [of excess stomach acid (hyperacidity).    |    j

'Before taking (gaviscon Double Action Mint Flavour [Chewable Tablets:    i    i    I

1    1    1    I

Do not take this product if you know you are allergic to any of the ingredients as very rarely difficulty m breathing and skin rashes have Recurred (see further information fo( a full list of ingredients).

[Take special ca[re before treatment with Gaviscon Double Action ^Mint Flavour phewable Tablets:    [    [

'This medicine contains small amounts of sodium (9.64 mmol per four tablet dose) and calcium (7.5 mmol per four tablet dose). ,

[If you have beer) advised to follow a (diet restricted in either of these please consult your doctor.    '    '

If you have phenylketonuria, note that the product is sweetened with ^spartame, a source of phenylalanine}    [

These tablets contain carmoisine lake (El22) which may cause allergic reactions.    i    i    i

You can take this product if you are pregnant or breast feeding.

Taking Other Medicines    '    1

t)o not take this! product within two    hours of taking other medicines by

)nouth as it can Interfere with the action of some other medicines.

This is especially important if you are taking antihistamines, antibiotics (tetracyclines and quinolones such as norfloxacin), iron preparation, hntifungals such[ as ketoconazole, di^oxin and beta-blockers (for heart Conditions), neuroleptics (for mental} illness), thyroxine, Chloroquine (for malaria) and bisphosphonates (for osteoporosis). i M25866______1____________1_____________1__________



How to take GavisconTJoubre Action MintTIavour Chewahle Tablets:!

1 . . 1 1 1 'For oral administration. Chew thoroughly before swallowing.

Adults and chilldren 12 year and over: When symptoms occur take |two to four tablets after meals and atj bedtime, up to fourjtimes a day. i Children under 12 years: Should only he taken on medical advice. | [If you forget a dpse, it is not necessajry to double the dosf next time, just i carry on taking as before.    |    |    |

[If you take too many tablets you may feel bloated. It is uhlikely to cause! you any harm, hut please consult your doctor or pharmaoist.

I    I    I

After taking Gaviscon Double Action Mint Flavour Ohewable [Tablets: If symptoms persist after 7!days consult your doctor.

Possible side effects:    i    i    [

Very rarely (less than 1 in 10,000 parents treated) an allergic reaction to1 [the ingredients rjiay occur. Symptonjs of this may includy: skin rash i itching, difficulty breathing, dizziness, swelling of the face, tongue or [ [throat. If you experience these or any other side effects, stop taking the product and consult your doctor imn[iediately.    j    i

[If you get any si[de effects, talk to ycjur doctor, pharmacist or nurse. This' includes any possible side effects not listed in this leaflet You can also ! report side effects directly via the Yellow Card Scheme at    [

)vww.mhra.gov.(ik/yellowcard    |    |    '

[By reporting sidy effects you can help provide more information on the i safety of this medicine.    i    i    [

Storing your medicine:    1    1    [

t)o not use this product after the expiry date (EXP: montb/year) shown. [ Jteep out of the [■each and sight of children, bo not store [above 30°C.    '

[Store in the original package.    [    j    [

Further information:    [    [    i

[Gaviscon Doubl^ Action Mint Flavoijr Chewahle Tablets circular, pink' Und white chewahle tablets with the odour and flavour of peppermint. Each chewahle tablet contains 250mg sodium alginate, 106.5mg sodium [ bicarbonate and )87.5mg calcium carbonate as the active ingredients. The dther ingredient^ are xylitol, carmelldse sodium, magnesiu[m stearate, macrogol 20,000, mannitol (E421), copovidone, acesulfame-K, aspartame [ (E951), mint flavour and carmoisine lake (E122). These tablets do not yontain sugar or gluten. Gaviscon Dojible Action Mint Flayour Chewahle i Tablets are available in pack sizes of 8’s, 16’s & 32’s.    i    [

Manufacturer and PL Holder in UK:1    1    [

iReckitt Benckiser Healthcare (UK) i,td., Hull, HU8 7DS[    [

Gaviscon and (^)    are trade marks.'    j    |

Text Revised: Jdne 2013    [    j    I

pL 00063/0525 [    [    [

0125866______1____________1_____________1__________1